Pegylated liposomal tumor necrosis factor‐α results in reduced toxicity and synergistic antitumor activity after systemic administration in combination with liposomal doxorubicin (Doxil®) in soft tissue sarcoma‐bearing ratsTimo L.M. ten Hagen, Alexander M.M. Eggermont, Sandra T. van Tiel et al.|International Journal of Cancer|2001Cited by 64
Biodistribution and tumor localization of stealth liposomal tumor necrosis factor-α in soft tissue sarcoma bearing ratsA.H. van der Veen, Timo L.M. ten Hagen, Alexander M.M. Eggermont et al.|International Journal of Cancer|1998Cited by 50